chartexchange

CELC
Celcuity Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
55.55USD-4.241%(-2.46)1,011,908
Pre-marketNov 18, 2026 9:27:30 AM EST
58.01USD0.000%(0.00)
After-hoursNov 18, 2026 4:00:30 PM EST
55.60USD+0.090%(+0.05)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Minneapolis, MN, USA
Previous Close
$58.01
Beta
1.19
52-Week High
$151.02 2026-05-04
52-Week Low
$53.54 2026-10-16
SMA 50
$70.38
SMA 200
$97.66
Avg. Vol 10D
1.07M
Avg. Vol 30D
1.48M
Avg. Vol 90D
1.30M
Relative Vol
0.68
29.91M
10,303,095
0.2600%
1,400,000
15,904
CELC Profile

celcuity is a biotech company developing state-of-the-art cell-based assays using our proprietary functional cellular analysis platform. we directly assess the functionality of the disease-related signaling pathways of a patient's diseased cells ex vivo to determine whether a drug therapy has the intended effect on those cells. the patient specific cellular data we provide offers clinicians and pharmaceutical companies unique insight into a patient's response to a drug therapy, and it will change the paradigm of personalized medicine.

CELC Performance
PeriodPriceDateChangeBeta
1W64.172026-11-12-13.36%2.487
1M57.122026-10-19-2.66%1.509
3M93.652026-08-19-40.63%1.609
6M130.962026-05-19-57.54%1.306
1Y94.232025-11-19-40.99%1.185
2Y12.472024-11-19+345.87%—
5Y16.072021-11-19+245.99%0.886
CELC Stock Summary

Celcuity Inc. Common Stock (NASDAQ:CELC) stock price today is $55.60, and today's volume is 1,011,908. CELC is down 4.154% today. The 30 day average volume is 1.48M. CELC market cap is $2.72B with 48.93M shares outstanding.